{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:59:13Z","timestamp":1791644353823,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004043","name":"Kanazawa Medical University","doi-asserted-by":"publisher","award":["2012-04"],"award-info":[{"award-number":["2012-04"]}],"id":[{"id":"10.13039\/501100004043","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.biopha.2022.113111","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T14:22:55Z","timestamp":1652797375000},"page":"113111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Epigallocatechin-3-gallate inhibits osteopontin expression and prevents experimentally induced hepatic fibrosis"],"prefix":"10.1016","volume":"151","author":[{"given":"Joseph","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsumi","family":"Tsuchishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikihiro","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113111_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.671640","article-title":"Cellular mechanisms of liver fibrosis","volume":"12","author":"Acharya","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.biopha.2022.113111_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0300-483X(00)00352-8","article-title":"Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen","volume":"156","author":"George","year":"2001","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.biopha.2022.113111_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0167-4838(95)00202-2","article-title":"Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen","volume":"1292","author":"George","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.biopha.2022.113111_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cbi.2011.07.001","article-title":"Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches","volume":"193","author":"Mormone","year":"2011","journal-title":"Chem. Biol. Interface"},{"issue":"1","key":"10.1016\/j.biopha.2022.113111_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2119\/molmed.2014.00048","article-title":"Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis","volume":"20","author":"Minato","year":"2014","journal-title":"Mol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2022.113111_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1515\/hsz-2017-0260","article-title":"Determination of selenium during pathogenesis of hepatic fibrosis employing hydride generation and inductively coupled plasma mass spectrometry","volume":"399","author":"George","year":"2018","journal-title":"Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2022.113111_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1139\/O08-038","article-title":"Elevated serum beta-glucuronidase reflects hepatic lysosomal fragility following toxic liver injury in rats","volume":"86","author":"George","year":"2008","journal-title":"Biochem. Cell Biol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113111_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0009-8981(03)00285-7","article-title":"Ascorbic acid concentrations in dimethylnitrosamine-induced hepatic fibrosis in rats","volume":"335","author":"George","year":"2003","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2022.113111_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12967-021-02854-x","article-title":"The roles and mechanisms of hypoxia in liver fibrosis","volume":"19","author":"Cai","year":"2021","journal-title":"J. Transl. Med."},{"issue":"22","key":"10.1016\/j.biopha.2022.113111_bib10","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1111\/bph.15258","article-title":"Inhibition of \u03b3-glutamyltransferase ameliorates ischaemia-reoxygenation tissue damage in rats with hepatic steatosis","volume":"177","author":"Kubota","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2022.113111_bib11","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1111\/jcmm.13304","article-title":"MMP-13 deletion decreases profibrogenic molecules and attenuates N-nitrosodimethylamine-induced liver injury and fibrosis in mice","volume":"21","author":"George","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"10.1016\/j.biopha.2022.113111_bib12","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.gt.3302929","article-title":"siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats","volume":"14","author":"George","year":"2007","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.biopha.2022.113111_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1357-2725(03)00253-X","article-title":"Expression of hyaluronic acid in N-nitrosodimethylamine induced hepatic fibrosis in rats","volume":"36","author":"George","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113111_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/1357-2725(95)00140-9","article-title":"Glycoprotein metabolism in dimethylnitrosamine induced hepatic fibrosis in rats","volume":"28","author":"George","year":"1996","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"23","key":"10.1016\/j.biopha.2022.113111_bib15","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.1073\/pnas.83.23.8819","article-title":"Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence","volume":"83","author":"Oldberg","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3\u20134","key":"10.1016\/j.biopha.2022.113111_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12079-009-0068-0","article-title":"The role of osteopontin in inflammatory processes","volume":"3","author":"Lund","year":"2009","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.biopha.2022.113111_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","article-title":"The multiple functions and mechanisms of osteopontin","volume":"59","author":"Icer","year":"2018","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2022.113111_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/hepr.12166","article-title":"Osteopontin: Versatile modulator of liver diseases","volume":"44","author":"Nagoshi","year":"2014","journal-title":"Hepatol. Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113111_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/hep.24701","article-title":"Nieto N. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin \u03b1(V)\u03b2(3) engagement and PI3K\/pAkt\/NF\u03baB signaling","volume":"55","author":"Urtasun","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2022.113111_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118744","article-title":"Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection","volume":"10","author":"Matsue","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.biopha.2022.113111_bib21","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","article-title":"Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications","volume":"82","author":"Singh","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113111_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ejphar.2015.05.005","article-title":"Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet","volume":"761","author":"Ding","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113111_bib23","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1177\/0300060516662735","article-title":"Epigallocatechin-3-gallate protects against hepatic ischaemia-reperfusion injury by reducing oxidative stress and apoptotic cell death","volume":"44","author":"Tak","year":"2016","journal-title":"J. Int. Med. Res."},{"issue":"7","key":"10.1016\/j.biopha.2022.113111_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0009-9120(00)00170-3","article-title":"Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamine","volume":"33","author":"George","year":"2000","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.biopha.2022.113111_bib25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41598-018-37516-4","article-title":"Alteration of trace elements during pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis","volume":"9","author":"George","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2022.113111_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41419-018-1272-8","article-title":"Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis","volume":"10","author":"George","year":"2019","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.biopha.2022.113111_bib27","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00109-020-01950-7","article-title":"Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent models","volume":"98","author":"George","year":"2020","journal-title":"J. Mol. Med."},{"issue":"7","key":"10.1016\/j.biopha.2022.113111_bib28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0009-9120(00)00170-3","article-title":"Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamine","volume":"33","author":"George","year":"2000","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2022.113111_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3164\/jcbn.22.51","article-title":"Lactate dehydrogenase isoenzymes in dimethylnitrosamine induced hepatic fibrosis","volume":"22","author":"George","year":"1997","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113111_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cccn.2004.05.018","article-title":"Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury","volume":"348","author":"George","year":"2004","journal-title":"Clin. Chim. Acta"},{"issue":"10","key":"10.1016\/j.biopha.2022.113111_bib31","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.clinbiochem.2006.07.002","article-title":"Mineral metabolism in dimethylnitrosamine-induced hepatic fibrosis","volume":"39","author":"George","year":"2006","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.biopha.2022.113111_bib32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.toxrep.2016.03.001","article-title":"Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia","volume":"3","author":"Ramachandran","year":"2016","journal-title":"Toxicol. Rep."},{"issue":"48","key":"10.1016\/j.biopha.2022.113111_bib33","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.3748\/wjg.v11.i48.7620","article-title":"Morphological and serum hyaluronic acid, laminin and type IV collagen changes in dimethylnitrosamine-induced hepatic fibrosis of rats","volume":"11","author":"Li","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2022.113111_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172681","article-title":"Recombinant thrombomodulin prevented hepatic ischemia-reperfusion injury by inhibiting high-mobility group box 1 in rats","volume":"863","author":"Hirakawa","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113111_bib35","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/antiox10071076","article-title":"Green Tea and Epigallocatechin Gallate (EGCG) for the management of Nonalcoholic Fatty Liver Diseases (NAFLD): insights into the role of oxidative stress and antioxidant mechanism","volume":"10","author":"Tang","year":"2021","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.biopha.2022.113111_bib36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/01635580903285049","article-title":"Molecular mechanisms of green tea polyphenols","volume":"61","author":"Dou","year":"2009","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.biopha.2022.113111_bib37","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.yrtph.2018.03.019","article-title":"The safety of green tea and green tea extract consumption in adults - results of a systematic review","volume":"95","author":"Hu","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113111_bib38","doi-asserted-by":"crossref","first-page":"4049098","DOI":"10.1155\/2017\/4049098","article-title":"Osteopontin at the crossroads of inflammation and tumor progression","volume":"2017","author":"Castello","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2022.113111_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2013.02.011","article-title":"Reactive oxygen species and the free radical theory of aging","volume":"60","author":"Liochev","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2022.113111_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113993","article-title":"Metabolism and interactions of antileprosy drugs","volume":"177","author":"George","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113111_bib41","doi-asserted-by":"crossref","unstructured":"Hrycay EG, Bandiera SM. Involvement of cytochrome P450 in reactive oxygen species formation and cancer. In: Advances in Pharmacology Vol. 74, 2015; pp. 35\u201384. Edited by Hardwick JP. \u3008https:\/\/doi.org\/10.1016\/bs.apha.2015.03.003\u3009.","DOI":"10.1016\/bs.apha.2015.03.003"},{"issue":"12","key":"10.1016\/j.biopha.2022.113111_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167435","article-title":"Epigallocatechin-3-gallate upregulates miR-221 to inhibit osteopontin-dependent hepatic fibrosis","volume":"11","author":"Arffa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113111_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113111_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mam.2007.09.016","article-title":"4-Hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases","volume":"29","author":"Poli","year":"2008","journal-title":"Mol. Asp. Med."},{"issue":"2","key":"10.1016\/j.biopha.2022.113111_bib45","doi-asserted-by":"crossref","first-page":"G305","DOI":"10.1152\/ajpgi.00439.2015","article-title":"GGsTop, a novel and specific \u03b3-glutamyl transpeptidase inhibitor, protects hepatic ischemia-reperfusion injury in rats","volume":"311","author":"Tamura","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113111_bib46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.numecd.2005.05.003","article-title":"A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress","volume":"15","author":"Del Rio","year":"2005","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.biopha.2022.113111_bib47","doi-asserted-by":"crossref","first-page":"3085756","DOI":"10.1155\/2019\/3085756","article-title":"Oxidative stress and advanced lipoxidation and glycation end products (ALEs and AGEs) in aging and age-related diseases","volume":"2019","author":"Moldogazieva","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"22","key":"10.1016\/j.biopha.2022.113111_bib48","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.3390\/app9224821","article-title":"Epigallocatechin-3-gallate (E.G.C.G.), an active constituent of green tea: implications in the prevention of liver injury induced by diethylnitrosamine (DEN) in rats","volume":"9","author":"Almatroodi","year":"2019","journal-title":"Appl. Sci."},{"issue":"48","key":"10.1016\/j.biopha.2022.113111_bib49","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113111_bib50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2022.113111_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108051","article-title":"Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis","volume":"99","author":"Yang","year":"2021","journal-title":"Int. Immunopharmacol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222005005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222005005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:56:59Z","timestamp":1787597819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222005005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":51,"alternative-id":["S0753332222005005"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113111","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigallocatechin-3-gallate inhibits osteopontin expression and prevents experimentally induced hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113111"}}